ICON 2013: Practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breast cancer.

Simple item page
dc.contributor.authorParikh, P M
dc.contributor.authorGupta, S
dc.contributor.authorDawood, S
dc.contributor.authorRugo, H
dc.contributor.authorBhattacharyya, G S
dc.contributor.authorAgarwal, A
dc.contributor.authorChacko, R
dc.contributor.authorSahoo, T P
dc.contributor.authorBabu, G
dc.contributor.authorAgarwal, S
dc.contributor.authorMunshi, A
dc.contributor.authorGoswami, C
dc.contributor.authorSmruti, B K
dc.contributor.authorBondarde, S
dc.contributor.authorDesai, C
dc.contributor.authorRajappa, S
dc.contributor.authorSomani, N
dc.contributor.authorSingh, M
dc.contributor.authorNimmagadda, R
dc.contributor.authorPavitran, K
dc.contributor.authorMehta, A
dc.contributor.authorParmar, V
dc.contributor.authorDesai, S
dc.contributor.authorNair, R
dc.contributor.authorDoval, D
dc.date.accessioned2014-12-29T11:35:38Z
dc.date.available2014-12-29T11:35:38Z
dc.date.issued2014-01
dc.description.abstractThe management of hormone receptor‑positive Her2‑negative breast cancer patients with advanced or metastatic disease is a common problem in India and other countries in this region. This expert group used data from published literature, practical experience, and opinion of a large group of academic oncologists, to arrive at practical consensus recommendations for use by the community oncologists.en_US
dc.identifier.citationParikh P M, Gupta S, Dawood S, Rugo H, Bhattacharyya G S, Agarwal A, Chacko R, Sahoo T P, Babu G, Agarwal S, Munshi A, Goswami C, Smruti B K, Bondarde S, Desai C, Rajappa S, Somani N, Singh M, Nimmagadda R, Pavitran K, Mehta A, Parmar V, Desai S, Nair R, Doval D. ICON 2013: Practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breastcancer. Indian Journal of Cancer. 2014 Jan-Mar; 51(1): 73-79.en_US
dc.identifier.urihttps://imsear.searo.who.int/handle/123456789/154291
dc.language.isoenen_US
dc.source.urihttps://www.indianjcancer.com/article.asp?issn=0019-509X;year=2014;volume=51;issue=1;spage=73;epage=79;aulast=Parikhen_US
dc.subjectChemotherapyen_US
dc.subjectdeveloping countriesen_US
dc.subjectendocrine therapyen_US
dc.subjectguidelinesen_US
dc.subjectwomenen_US
dc.subject.meshBreast Neoplasms --metabolism
dc.subject.meshBreast Neoplasms --secondary
dc.subject.meshBreast Neoplasms --therapy
dc.subject.meshCombined Modality Therapy
dc.subject.meshConsensus
dc.subject.meshDisease Management
dc.subject.meshFemale
dc.subject.meshHumans
dc.subject.meshPractice Guidelines as Topic
dc.subject.meshReceptors, ErbB-2 --metabolism
dc.subject.meshReceptors, Estrogen --metabolism
dc.subject.meshReceptors, Progesterone --metabolism
dc.subject.meshSocieties, Medical
dc.titleICON 2013: Practical consensus recommendations for hormone receptor-positive Her2-negative advanced or metastatic breast cancer.en_US
dc.typeArticleen_US
Files
Original bundle
Now showing 1 - 1 of 1
Thumbnail Image
Name:
ijc2014v51n1p73.pdf
Size:
421.42 KB
Format:
Adobe Portable Document Format
Description:
Oncology Gold Standard Consensus Recommendation
Download
License bundle
Now showing 1 - 1 of 1
No Thumbnail Available
Name:
license.txt
Size:
1.71 KB
Format:
Item-specific license agreed upon to submission
Description:
Download
Collections
Indian Journal of Cancer